United States News Todas as matérias

Precigen (NASDAQ:PGEN), a biopharmaceutical company specializing in the development of gene and cell therapies, has announced a significant acceleration in the commercial rollout of PAPZIMEOS™ (zopapogene imadenovec-drba), projecting first-quarter 2026 revenue to exceed $18 million.

Soleno Therapeutics (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel treatments for rare diseases, announced on April 7, 2026, that it has voluntarily withdrawn its Marketing Authorization Application (MAA) from the European Medicines Agency (EMA) for VIOKAT prolonged-release tablets.

MarketAxess Holdings (NASDAQ:MKTX), the operator of a leading electronic trading platform for fixed-income securities, reported record total credit average daily volume (ADV) for both March 2026 and the first quarter ended March 31, 2026, driven by a surge in portfolio and block trading activity.

Bluejay Diagnostics (NASDAQ:BJDX), a medical technology firm specializing in rapid near-patient testing, announced on April 7, 2026, that it has successfully enrolled 624 patients in its pivotal SYMON-II clinical trial.

Nuvalent (NASDAQ:NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, announced on April 7, 2026, the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for neladalkib.

Ascendis Pharma (NASDAQ:ASND) has officially commenced the commercial launch of YUVIWEL® (navepegritide) in the United States, marking the availability of the first once-weekly treatment for pediatric patients with achondroplasia.

Greenwich LifeSciences (NASDAQ:GLSI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences, has filed new patent claims that could significantly expand the addressable market for its lead candidate, GLSI-100.

Lifezone Metals (NYSE:LZM) has announced the first successful production of platinum, palladium, and rhodium from U.S.-sourced spent automotive catalytic converters, marking a technical milestone for its proprietary Hydromet Technology.

Pony.ai (NASDAQ:PONY), a global leader in autonomous driving technology, has reached a critical milestone in its international commercialization roadmap, receiving regulatory approval on April 7, 2026, to begin "by-invite" autonomous rides in Singapore.

Pershing Square, led by billionaire investor Bill Ackman, has proposed a transformative merger between its acquisition vehicle and Universal Music Group (UMG) to relocate the world’s largest music label’s primary listing to the New York Stock Exchange.

Organogenesis Holdings (NASDAQ:ORGO), a leader in regenerative medicine, has announced positive topline results from a prospective, multi-center randomized controlled trial (RCT) evaluating PuraPly AM for the treatment of diabetic foot ulcers (DFUs).

Telix Pharmaceuticals (NASDAQ:TLX), a global leader in radiopharmaceutical precision medicine, has reported Q1 2026 group revenue of $230 million, representing a 24% increase over the same period last year and an 11% sequential rise from the previous quarter.

Deere & Company (NYSE:DE) has reached a definitive agreement to resolve a consolidated multidistrict "right to repair" lawsuit, agreeing to pay $99 million into a class settlement fund for eligible farmers and ranchers.

Mesoblast (NASDAQ:MESO), a global leader in allogeneic cellular medicines, has reported net sales of $30.3 million for its flagship product, Ryoncil (remestemcel-L-rknd), for the third fiscal quarter ended March 31, 2026.

NorthStrive Defense Tech (NASDAQ:ELAB) has moved to bolster its maritime and littoral combat portfolio, announcing it has secured an exclusive option to license a specialized multi-domain drone system under U.S. Patent No. 12,291,334.

Deckorators, a leading brand of UFP Industries (NYSE:UFPI), has completed the acquisition of the remaining operating assets for MoistureShield decking, significantly expanding its manufacturing footprint and proprietary technology portfolio in the high-growth wood-plastic composite (WPC) market.

Jet.AI (NASDAQ:JTAI), a developer of artificial intelligence-driven software for the private aviation industry, has announced a 1-for-200 reverse stock split effective before the market opens on April 8, 2026.

Oncolytics Biotech (NASDAQ:ONCY) has scheduled a Type C meeting with the U.S. Food and Drug Administration (FDA) for April 16, 2026, to align on a formal registrational development path for its lead immunotherapy candidate, pelareorep, in patients with advanced anal cancer.

Mobix Labs (NASDAQ:MOBX), a fabless semiconductor and connectivity company, has been awarded a $3.2 million order for mission-critical technology integrated into the airport body scanners utilized by the Transportation Security Administration (TSA) across the United States.

Stereotaxis (NYSE:STXS), a pioneer in innovative robotic technologies for the treatment of cardiac arrhythmias, announced on April 6, 2026, that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Synchrony™ interventional lab display system.

ParaZero Technologies (NASDAQ:PRZO), an aerospace defense company specializing in autonomous drone safety and interception solutions, has received a follow-on purchase order from an Israeli defense entity for its advanced DefendAir Counter-Unmanned Aerial Systems (C-UAS).

FuboTV (NYSE:FUBO) has unveiled a robust multi-year financial roadmap, setting its sights on significant profitability milestones as the company matures from a high-growth streaming challenger into a scaled, cash-generative media platform.

Amgen (NASDAQ:AMGN) has announced positive topline results from its Phase 3 clinical trial evaluating a subcutaneous formulation of TEPEZZA (teprotumumab-trbw) for adults with moderate-to-severe active Thyroid Eye Disease (TED).

Elbit Systems (NASDAQ:ESLT) has been awarded a contract valued at approximately $750 million (€650 million) to supply its Precise & Universal Launching System (PULS) rocket artillery to the Hellenic Armed Forces, marking a major expansion of the company’s presence in the European defense market.